Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous...

Area of Science:

• Pharmaceutical manufacturing
• Supply chain management
• Process engineering

Background:

• Current pharmaceutical supply chains rely on large-batch, centralized manufacturing, leading to inflexibility and high inventory.
• Evolving markets demand greater product variety, shorter lifecycles, and smaller volumes, straining existing models.
• Future supply chains must improve drug affordability and availability amidst increasing complexity.

Purpose of the Study:

• To examine opportunities and challenges of transitioning to continuous processing-based pharmaceutical supply chains.
• To explore the potential of pull-driven, demand-based supply chains utilizing continuous manufacturing.
• To outline the transformative potential for production, supply, and value chains.

Main Methods:

• Discussion paper analyzing future supply chain models.
• Examination of continuous manufacturing principles in pharmaceuticals.
• Analysis of inventory reduction, lead-time improvements, and product assurance.

Main Results:

• Significant opportunities exist for inventory reduction and decreased lead times to patients.
• Decentralized production models offer enhanced volume flexibility and greater product variety.
• Continuous processing enables different production, supply, and value chain footprints.
• Potential for cost savings in clinical trials and drug development, supporting faster market entry.

Conclusions:

• Adopting continuous supply chain operating models can transform the pharmaceutical industry.
• Hybrid or full continuous processing solutions can deliver right-first-time quality with lower inventory.
• This transformation is crucial for meeting future demands for affordability and availability.